Peter Dolliner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peter Dolliner has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Andreas Gleiss
Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria
1 shared publicationGuenter Steurer
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
1 shared publicationLeopold Stiebellehner
Division of Pneumology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
1 shared publicationLindsay Brammen
Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
1 shared publicationMartin Huelsmann
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
1 shared publicationPhilipp Ubl
Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
1 shared publication
Latest Publications
- 12 April 2013
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 102 (7) , 535-542
Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic
Background Sleep disordered breathing (SDB) has important clinical implications in patients with congestive heart failure (CHF). We performed portable recording in unselected CHF patients on contemporary therapy. Data on the interactions of SDB in patients supervised at heart failure clinics are rare and we illustrate diversities of obstructive sleep apnoea (OSA) and central sleep apnoea (CSA). Methods We studied 176 consecutive subjects on contemporary medical therapy with a median left ventricular ejection fraction of 25.0 % (range 7–35 %) and median NT-pro BNP levels of 3,413.0 pg/ml (range 305.1–35,000.0 pg/ml). Participants underwent prospective overnight portable recording. Results 50 % presented with an at least moderate form of nocturnal breathing disorder [apnoea–hypopnoea index (AHI) ≥15/h]. Only 15 patients (17.1 %) with AHI ≥15/h reported excessive daytime sleepiness. Irrespective of left ventricular ejection fraction, patients with CSA had higher levels of NT-pro BNP compared to patients with OSA (differences in medians = 2,639.0 pg/ml, p = 0.016), and compared to patients with an AHI p < 0.001). OSA affected 26 patients (14.8 %). Conclusions Patients with severe stable CHF on contemporary therapy have a prevalence of 50.0 % of moderate to severe SDB. The natural cascade of the failing heart is initially characterised by absent SDB or OSA, whereas end-stage CHF is associated with CSA.
- 12 April 2013
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 102 (7) , 535-542
Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic
Background Sleep disordered breathing (SDB) has important clinical implications in patients with congestive heart failure (CHF). We performed portable recording in unselected CHF patients on contemporary therapy. Data on the interactions of SDB in patients supervised at heart failure clinics are rare and we illustrate diversities of obstructive sleep apnoea (OSA) and central sleep apnoea (CSA). Methods We studied 176 consecutive subjects on contemporary medical therapy with a median left ventricular ejection fraction of 25.0 % (range 7–35 %) and median NT-pro BNP levels of 3,413.0 pg/ml (range 305.1–35,000.0 pg/ml). Participants underwent prospective overnight portable recording. Results 50 % presented with an at least moderate form of nocturnal breathing disorder [apnoea–hypopnoea index (AHI) ≥15/h]. Only 15 patients (17.1 %) with AHI ≥15/h reported excessive daytime sleepiness. Irrespective of left ventricular ejection fraction, patients with CSA had higher levels of NT-pro BNP compared to patients with OSA (differences in medians = 2,639.0 pg/ml, p = 0.016), and compared to patients with an AHI p < 0.001). OSA affected 26 patients (14.8 %). Conclusions Patients with severe stable CHF on contemporary therapy have a prevalence of 50.0 % of moderate to severe SDB. The natural cascade of the failing heart is initially characterised by absent SDB or OSA, whereas end-stage CHF is associated with CSA.